IDF-11774抑制内皮细胞HIF-1α可减轻视网膜新生血管和血管渗漏
本研究在缺氧培养的人脐静脉内皮细胞(HUVEC)、人视网膜微血管内皮细胞(HRMEC)及氧诱导视网膜病变(OIR)小鼠中,评估新型HIF-1α抑制剂IDF-11774对缺血性视网膜病变的治疗作用及机制;结果显示IDF-11774抑制HIF-1α表达、减少视网膜新生血管和血管渗漏并促进无灌注区血管再通,高剂量玻璃体腔注射未见视网膜电生理或组织学显著影响。
要点
- IDF-11774经蛋白酶体降解途径抑制缺氧诱导的HIF-1α表达,并抑制内皮细胞增殖、迁移和成管。
- OIR小鼠P12玻璃体腔注射IDF-11774 18.4 ng后,P17视网膜新生血管减少、血管渗漏减轻、无灌注区血管再通增加。
- 高剂量IDF-11774对视网膜电图和视网膜组织学无显著影响。
核心结论
- 抑制HIF-1α的IDF-11774具有多重治疗和通路调控作用,并表现出良好的视网膜安全性,提示其可能是缺血性视网膜病变的潜在治疗策略。
研究设计与样本
- 研究在缺氧暴露的HUVEC和HRMEC以及OIR模型小鼠中开展,评估IDF-11774的疗效与作用机制。
- OIR小鼠于P12玻璃体腔注射IDF-11774 18.4 ng或溶媒,P17分析视网膜新生血管和血管通透性。
- 采用RT-qPCR、免疫印迹、免疫染色、细胞增殖、划痕、Transwell和成管实验评估内皮细胞效应。
- 通过RNA测序鉴定靶基因,并用蛋白质印迹和免疫染色验证。
- 采用视网膜电图、TUNEL染色和免疫荧光染色评估玻璃体腔注射IDF-11774的视网膜毒性。
主要发现
- 在HUVEC中,IDF-11774通过蛋白酶体降解抑制缺氧诱导的HIF-1α表达,同时抑制增殖、迁移和成管。
- 在OIR小鼠中,IDF-11774显著减少视网膜新生血管、促进血管闭塞区血管再通并减轻血管渗漏。
- 在缺氧HUVEC、HRMEC及OIR小鼠中,IDF-11774调控关键血管调控信号通路ANGPT2/TIE2和PlGF。
- 高剂量IDF-11774对视网膜电图和视网膜组织学无显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In ischemic retinopathy (IR), hypoxia-inducible factor (HIF)-1α contributes to vision-threatening pathological retinal neovascularization (RNV). This study investigated the therapeutic efficacy and action mechanisms of the newly developed HIF-1α inhibitor IDF-11774 for IR in hypoxia-exposed human umbilical vein endothelial cells (HUVECs) and human retinal microvascular endothelial cells (HRMECs), as well as an oxygen-induced retinopathy (OIR) model mice. METHODS: The effect of IDF-11774 on HIF-1α expression in HUVECs was assessed by quantitative real-time polymerase chain reaction (RT-qPCR), immunoblotting, and immunostaining, and effects on angiogenic potential were evaluated by cell proliferation, scratch wound, Transwell, and tube formation assays. Pathological RNV and vascular permeability were analyzed by immunostaining, hematoxylin and eosin staining, and dye leakage assays on postnatal day (P)17 following intravitreal injection of IDF-11774 (18.4 ng) or vehicle at P12. Target genes were identified by RNA sequencing and validated by western blot and immunostaining. Electroretinography, TUNEL staining, and immunofluorescence staining were conducted to evaluate the retinal toxicity of intravitreal IDF-11774. RESULTS: In HUVECs, IDF-11774 inhibited hypoxia-induced HIF-1α expression through proteasomal degradation and concomitantly suppressed proliferation, migration, and tube formation. In OIR mice, IDF-11774 significantly reduced RNV, facilitated revascularization in the vascular obliterated zone, and alleviated vascular leakage. The key vascular regulatory signaling pathways ANGPT2/TIE2 and PlGF were modulated by IDF-11774 in hypoxic HUVECs and HRMECs, as well as in OIR mice. High-dose IDF-11774 had no significant effects on the electroretinogram or retinal histology. CONCLUSIONS: Inhibiting HIF-1α with IDF-11774 exerts multiple therapeutic and pathway-regulatory effects and demonstrates a favorable retinal safety profile, highlighting IDF-11774 as a potentially therapeutic strategy for IR.
引用
- Yang F, Lin J, Yang B, et al. Inhibition of Endothelial HIF-1α by IDF-11774 Attenuates Retinal Neovascularization and Vascular Leakage. Invest Ophthalmol Vis Sci. 2025. PMID: 40668060. doi:10.1167/iovs.66.9.47
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。